Clinical Trial: A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase 1 Pharmacokinetic Profiling Study in Patients Receiving Trientine Dihydrochloride for the Treatment of Wilson's Disease.

Brief Summary: To evaluate the effects of a single dose of trientine in children ≥6 years and adult patients with Wilson's disease.